Human NGF form comprising two mutations, a first mutation being represented by the substitution of the proline amino acid 61 with serine, a second mutation being represented by the substitution of an aminoacid in any of the positions 95-101, for the simultaneous use as agent for the activation of the chemokine SDF-1alpha and as an agent for the inhibition of the activity of the cytokine TNF alpha
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases
Capsoni Simona
2017
Abstract
Human NGF form comprising two mutations, a first mutation being represented by the substitution of the proline amino acid 61 with serine, a second mutation being represented by the substitution of an aminoacid in any of the positions 95-101, for the simultaneous use as agent for the activation of the chemokine SDF-1alpha and as an agent for the inhibition of the activity of the cytokine TNF alphaFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
